Jiangsu Hengrui Medicine
600276.SS
#484
Rank
โ‚ฌ40.59 B
Marketcap
6,36ย โ‚ฌ
Share price
-3.83%
Change (1 day)
5.32%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): 0,08608ย โ‚ฌ

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is 0,08683ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,08658ย โ‚ฌ a decrease over its 2021 EPS that were of 0,10ย โ‚ฌ.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,08608ย โ‚ฌ-0.59%
20220,08658ย โ‚ฌ-17.1%
20210,10ย โ‚ฌ-24.44%
20200,14ย โ‚ฌ20.3%
20190,11ย โ‚ฌ25.58%
20180,09149ย โ‚ฌ27.55%
20170,07173ย โ‚ฌ21.64%
20160,05897ย โ‚ฌ13.57%
20150,05192ย โ‚ฌ39.86%
20140,03713ย โ‚ฌ21.33%
20130,03060ย โ‚ฌ17.7%
20120,02600ย โ‚ฌ25.56%
20110,02070ย โ‚ฌ26.22%
20100,01640ย โ‚ฌ10.3%
20090,01487ย โ‚ฌ57.92%
20080,009417ย โ‚ฌ11.06%
20070,008479ย โ‚ฌ85.81%
20060,004563ย โ‚ฌ87.94%
20050,002428ย โ‚ฌ33.97%
20040,001812ย โ‚ฌ29.78%
20030,001396ย โ‚ฌ19.78%
20020,001166ย โ‚ฌ